JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

简称 J FORMOS MED ASSOC ·TAIWAN ·出版周期 Monthly ·年均收录 118 篇

2.5

最新影响因子

21.60%

自引率

容易

投稿难度

较慢,6-12周

审稿周期

期刊简介

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION（ISSN号0929-6646）是一本由中国台湾地区出版的医学期刊，出版周期为月刊，由Elsevier公司负责出版。该杂志的影响因子根据年份有所不同，近年来保持在2至3之间，属于SCI收录期刊，在中科院分区中通常位于医学类3区或4区。杂志为非开放获取（非OA）期刊。其发文特点主要涵盖临床医学、基础医学和公共卫生等领域，特别关注亚太地区的医学研究和实践成果，文章类型包括原创研究、综述和病例报告等。杂志的质量相对稳定，审稿流程较为严格，但由于影响因子中等，学术影响力主要集中在区域性读者群体中。潜在风险包括投稿竞争较激烈，且非OA模式可能限制文章的传播范围。总体而言，该杂志适合从事医学研究的学者投稿，尤其是在亚太地区有相关研究背景的科研人员。

影响因子趋势

近期发表

Long-term survival of patients who received atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma 2025-11-07

Trends of artificial intelligence/machine learning-enabled medical devices in Taiwan, 2020-2024 2026-04-24

Editorial Board 2026-09-09

Cervical cytology changes during COVID-19 2025-11-04

Impact of COVID-19 on cervical cancer screening: A cohort study 2025-10-23

Frailty risk in adults with dynapenia: A cross-sectional study comparing AWGS 2019 and GLIS 2024 consensus enhanced clinical utility 2025-11-05

Far infrared therapy improves the vascular function of lower extremities in hemodialysis patients 2025-08-29

Guide for Authors 2026-09-09

Comment on “Application of deep learning reconstruction in abdominal magnetic resonance cholangiopancreatography for image quality improvement and acquisition time reduction” 2026-02-06

Comment on “Diagnostic value and fracture healing-preventing effect of upregulated microRNA-4534 in patients with osteoporotic fractures” 2026-02-01